Insys Pharma Targeted By Group With Ties To Kyle Bass
An organization tied to hedge fund manager Kyle Bass filed petitions challenging two Insys Pharma Inc. patents for the pain medication Subsys on Monday, the same day the group was dealt...To view the full article, register now.
Already a subscriber? Click here to view full article